机译:对原发性胆管炎患者嗜虫酸和熊甲酸核糖酸的联合治疗对熊科糖酸不完全反应的患者:系统审查
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
Third Mil Med Univ Southwest Hosp Cholestat Liver Dis Ctr Dept Gastroenterol Chongqing Peoples;
randomized controlled trials; combination therapy; monotherapy; primary biliary cholangitis; obeticholic acid; ursodeoxycholic acid;
机译:对原发性胆管炎患者嗜虫酸和熊甲酸核糖酸的联合治疗对熊科糖酸不完全反应的患者:系统审查
机译:重度原发性胆汁性肝硬化患者仅对熊去氧胆酸没有反应时,使用熊去氧胆酸,布地奈德和霉酚酸酯的三联疗法。
机译:治疗原发性胆管炎尿嘧啶赤胆酸非响应者:系统审查
机译:核糖核酸酸治疗影响细胞因子网络,并对初级硬化胆管炎和原发性胆汁肝硬化患者发挥免疫调节作用
机译:定义肠道菌群,微生物衍生的次级胆汁酸熊去氧胆酸(UDCA)和艰难梭菌发病机理之间的动力学
机译:非诺贝特联合熊去氧胆酸联合治疗对UDCA单一疗法反应不完全的原发性胆汁性肝硬化患者的荟萃分析
机译:对肝细胞癌患者的联合治疗原发性胆汁肝硬化患者对UDCA单药治疗不完全的影响:META分析